| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Boulding Mark Elliott | EXEC. VP AND CLO | C/O PTC THERAPEUTICS, INC., 500 WARREN CORPORATE CENTER DRIVE, WARREN | /s/ Avraham S. Adler, Attorney-in-Fact | 2025-10-07 | 0001578852 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PTCT | Common Stock | Options Exercise | $714K | +18.1K | +17.44% | $39.42 | 122K | Oct 3, 2025 | Direct | F1 |
| transaction | PTCT | Common Stock | Sale | -$200K | -3.1K | -2.54% | $64.43 | 119K | Oct 3, 2025 | Direct | F1, F2 |
| transaction | PTCT | Common Stock | Sale | -$401K | -6.12K | -5.15% | $65.47 | 113K | Oct 3, 2025 | Direct | F1, F3 |
| transaction | PTCT | Common Stock | Sale | -$492K | -7.4K | -6.56% | $66.44 | 105K | Oct 3, 2025 | Direct | F1, F4 |
| transaction | PTCT | Common Stock | Sale | -$101K | -1.5K | -1.42% | $67.15 | 104K | Oct 3, 2025 | Direct | F1, F5 |
| transaction | PTCT | Common Stock | Options Exercise | $89.3K | +2.27K | +2.18% | $39.42 | 106K | Oct 3, 2025 | Direct | F1 |
| transaction | PTCT | Common Stock | Sale | -$34.5K | -536 | -0.5% | $64.43 | 106K | Oct 3, 2025 | Direct | F1, F6 |
| transaction | PTCT | Common Stock | Sale | -$54.2K | -824 | -0.78% | $65.73 | 105K | Oct 3, 2025 | Direct | F1, F7 |
| transaction | PTCT | Common Stock | Sale | -$60.4K | -906 | -0.86% | $66.63 | 104K | Oct 3, 2025 | Direct | F1, F8 |
| transaction | PTCT | Common Stock | Options Exercise | $89.3K | +2.27K | +2.18% | $39.42 | 106K | Oct 3, 2025 | Direct | F1 |
| transaction | PTCT | Common Stock | Sale | -$35.4K | -550 | -0.52% | $64.44 | 106K | Oct 3, 2025 | Direct | F1, F9 |
| transaction | PTCT | Common Stock | Sale | -$55.1K | -838 | -0.79% | $65.72 | 105K | Oct 3, 2025 | Direct | F1, F10 |
| transaction | PTCT | Common Stock | Sale | -$58.5K | -877 | -0.84% | $66.67 | 104K | Oct 3, 2025 | Direct | F1, F11 |
| transaction | PTCT | Common Stock | Options Exercise | $89.3K | +2.27K | +2.18% | $39.42 | 106K | Oct 6, 2025 | Direct | F1 |
| transaction | PTCT | Common Stock | Sale | -$147K | -2.27K | -2.13% | $65.07 | 104K | Oct 6, 2025 | Direct | F1, F12 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PTCT | Stock Option (Right to Buy) | Options Exercise | $0 | -18.1K | -50% | $0.00 | 18.1K | Oct 3, 2025 | Common Stock | 18.1K | $39.42 | Direct | F1, F13 |
| transaction | PTCT | Stock Option (Right to Buy) | Options Exercise | $0 | -2.27K | -12.5% | $0.00 | 15.9K | Oct 3, 2025 | Common Stock | 2.27K | $39.42 | Direct | F1, F13 |
| transaction | PTCT | Stock Option (Right to Buy) | Options Exercise | $0 | -2.27K | -14.28% | $0.00 | 13.6K | Oct 3, 2025 | Common Stock | 2.27K | $39.42 | Direct | F1, F13 |
| transaction | PTCT | Stock Option (Right to Buy) | Options Exercise | $0 | -2.27K | -16.67% | $0.00 | 11.3K | Oct 6, 2025 | Common Stock | 2.27K | $39.42 | Direct | F1, F13 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024. |
| F2 | This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.00 to $64.95 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F3 | This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $65.00 to $65.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F4 | This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $66.00 to $66.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F5 | This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $67.00 to $67.29 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F6 | This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.00 to $64.95 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F7 | This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $65.26 to $66.04 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F8 | This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $66.42 to $67.08 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F9 | This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.00 to $64.95 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F10 | This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $65.26 to $66.08 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F11 | This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $66.42 to $67.07 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F12 | This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.72 to $65.38 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F13 | This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024. |